AI drug discovery

NVIDIA research

(Photo Credit: NVIDIA) 

By  Laura Lovett 10:58 am April 12, 2021
Silicon Valley giant NVIDIA is teaming up with pharma company AstraZeneca and the University of Florida on new artificial intelligence research projects aimed at boosting drug discovery and patient care. This morning NVIDIA and AstraZeneca revealed a new drug-discovery model called MegaMoIBART, which is aimed at "reaction prediction, molecular optimization and de novo molecular generation."...
By  Dave Muoio 12:13 pm March 15, 2021
insitro, an artificial intelligence drug discovery startup, has added a $400 million Series C round to its already impressive fundraising haul. The financing is set to close during the first full week of April, according to the company. Canadian Pension Plan Investment Board led the raise, which also included a laundry list of participants. These names include: Andreessen Horowitz, funds and...
Paperwork is handed off between two people
By  Dave Muoio 03:17 pm October 29, 2020
This morning Israeli "Digital X-ray" company Nanox announced a new deal with medical data and image management firm Ambra Health. The agreement will see Ambra's cloud software integrated with the digital component of Nanox's in-development imaging systems, and according to the companies will streamline image management while making it easier to access for providers and patients. "It is our intent...
By  Dave Muoio 12:21 pm May 26, 2020
insitro and Exscientia, two platforms using artificial intelligence to drive the discovery of new drugs, announced this morning the raise of $143 million and $60 million, respectively, from investors. insitro's oversubscribed Series B round was headed by Andreessen Horowitz, and joined by new backers Canada Pension Plan Investment Board, T. Rowe Price Associates, BlackRock, Casdin Capital, HOF...